Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action.
Marycz K, Sobierajska P, Roecken M, Kornicka-Garbowska K, Kępska M, Idczak R, Nedelec JM, Wiglusz RJ. Marycz K, et al. Among authors: kepska m. J Nanobiotechnology. 2020 Feb 18;18(1):33. doi: 10.1186/s12951-020-00590-w. J Nanobiotechnology. 2020. PMID: 32070362 Free PMC article.
Aminopropyltriethoxysilane (APTES)-Modified Nanohydroxyapatite (nHAp) Incorporated with Iron Oxide (IO) Nanoparticles Promotes Early Osteogenesis, Reduces Inflammation and Inhibits Osteoclast Activity.
Marycz K, Kornicka-Garbowska K, Patej A, Sobierajska P, Kotela A, Turlej E, Kepska M, Bienko A, Wiglusz RJ. Marycz K, et al. Among authors: kepska m. Materials (Basel). 2022 Mar 11;15(6):2095. doi: 10.3390/ma15062095. Materials (Basel). 2022. PMID: 35329547 Free PMC article.
Correction to: Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action.
Marycz K, Sobierajska P, Roecken M, Kornicka-Garbowska K, Kępska M, Idczak R, Nedelec JM, Wiglusz RJ. Marycz K, et al. Among authors: kepska m. J Nanobiotechnology. 2020 May 19;18(1):79. doi: 10.1186/s12951-020-00631-4. J Nanobiotechnology. 2020. PMID: 32430051 Free PMC article.
Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions - a perspective in vitro model for drug testing.
Śmieszek A, Marcinkowska K, Małas Z, Sikora M, Kępska M, Nowakowska BA, Deperas M, Smyk M, Rodriguez-Galindo C, Raciborska A. Śmieszek A, et al. Among authors: kepska m. BMC Cancer. 2024 Feb 12;24(1):105. doi: 10.1186/s12885-023-11807-0. BMC Cancer. 2024. PMID: 38342891 Free PMC article.
11 results